Related Experiment Video
Updated: Apr 6, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Agreement among cardiovascular disease risk calculators
G Michael Allan1, Faeze Nouri, Christina Korownyk
1Evidence-Based Medicine, Department of Family Medicine, University of Alberta, Room 1706 College Plaza, 8215-112 St NW, Edmonton, Alberta T6G 2C8, Canada. michael.allan@ualberta.ca
Cardiovascular disease risk calculators show significant variability in risk assessment, impacting patient categorization and treatment guidelines. Choosing a calculator greatly influences risk estimates and assigned categories.
Area of Science:
- Cardiology
- Medical Informatics
- Public Health
Background:
- Cardiovascular disease risk calculators are widely recommended by clinical guidelines.
- Limited research exists on the consistency of risk assessment across different calculators.
- Guideline recommendations for calculator use necessitate understanding their comparative performance.
Purpose of the Study:
- To evaluate the consistency and variability in cardiovascular disease risk estimation among commonly used risk calculators.
- To compare risk categorization and absolute risk estimates generated by different calculators for hypothetical patients.
- To assess the implications of calculator variability on clinical decision-making and guideline adherence.
Main Methods:
- A systematic search identified 25 cardiovascular disease risk calculators.
- 128 unique hypothetical patients were generated based on 7 dichotomized risk factors.
- Two clinicians independently assessed each patient using each selected calculator, comparing risk estimates and categories.
Main Results:
- Significant variability was observed in risk categorization, with calculators assigning patients to a mean of 2.2 categories.
- Risk category agreement between calculator pairs was only 67%.
- For the same patient, the highest calculated risk estimate averaged 4.9 times higher than the lowest, irrespective of diabetes status.
Conclusions:
- The choice of cardiovascular disease risk calculator significantly impacts both risk categorization and absolute risk estimates.
- This variability has substantial implications for clinical guidelines that recommend therapies based on specific calculator outputs.
- Standardization or clear guidance on calculator selection is needed to ensure consistent patient management.
Related Concept Videos
Pre-Procedural Guidelines for Assessing Blood Pressure
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Relative Risk
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease IV: Preventive Measures
Hazard Ratio
For example, in a clinical trial...

